ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
Geneva, Switzerland and Boston, MA – Thursday 11 February, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, announced today that its board of directors approved on February 10, 2021 an increase of its share capital from 69,629,347 to 81,220,471 through the issue of 11,591,124 new registered shares at an issue price of 1/13 of a Swiss Franc each, after registration of 3,406,480 new shares issued out of the company’s conditional share capital. The 11,591,124 new shares, to be issued out of the company’s authorized capital, will be fully subscribed for by ObsEva USA Inc., its 100% wholly owned subsidiary, and listed on the SIX Swiss Exchange on or around February 18, 2021. The transaction has been decided to provide the group with additional treasury shares that can be used in the future to raise funds in an efficient manner, as well as for the equity plans of the company and its subsidiaries.
ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor, and improving IVF outcomes. ObsEva is listed on the Nasdaq Global Select Market and is trading under the ticker symbol "OBSV" and on the SIX Swiss Exchange where it is trading under the ticker symbol "OBSN". For more information, please visit www.ObsEva.com.
For further information, please contact:
CEO Office Contact:
+41 22 552 1550
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Totalbanken A/S26.2.2021 10:36:41 CET | Press release
Totalbanken A/S indkalder til ordinær generalforsamling
Sievi Capital Oyj26.2.2021 10:31:38 CET | Press release
Sievi Capital Plc: Managers' Transactions
Plc Uutechnic Group Oyj26.2.2021 10:31:28 CET | Press release
Plc Uutechnic Group Oyj: Special representative appointed for the arbitration proceedings concerning the redemption of the minority shares in Plc Uutechnic Group Oyj
Danske Invest26.2.2021 10:20:54 CET | Press release
Anmodning om ophør af suspension i Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select
Sveriges Riksbank26.2.2021 10:08:32 CET | Press release
RESULT OF RIKSBANK REVERSED AUCTIONS SEK GOVERNMENT BONDS
Skeljungur hf.26.2.2021 10:08:21 CET | Press release
Skeljungur hf.: Restructuring and organizational changes at Skeljungur
Municipality Finance Plc26.2.2021 10:01:41 CET | Press release
Municipality Finance issues EUR 40 million notes under MTN programme
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom